The 13th GCB Biomedical Science and Engineering Symposium was held on August 8, 2026, at Hokkaido University in collaboration with Stanford University’s Department of Radiation Oncology. Conducted in a hybrid format, the event welcomed 107 participants, primarily from abroad, highlighting the Global Center for Biomedical Science and Engineering’s international initiatives.

The morning session focused on "Innovative Advances in Radiation Therapy," addressing cutting-edge technologies like upright proton therapy and novel treatment strategies utilizing immune cell dose evaluation. The afternoon session addressed "Quantum Computing and AI," exploring rapidly advancing quantum technologies and their application in drug discovery and healthcare.

The symposium featured a diverse lineup of speakers from academia, clinical institutions, and industry, including Stanford, Hokkaido University, Chang Gung Memorial Hospital, IBM, and Fujitsu. Their presentations offered multidisciplinary insights bridging advanced radiation techniques and emerging computational fields.

Each session included active Q&A discussions, providing a valuable platform for fostering international research collaboration and industry-academic partnerships. The event fostered vibrant interdisciplinary exchange and reaffirmed GCB’s commitment to advancing global collaboration and cultivating internationally capable professionals in biomedical science and engineering.